VaxiPatch™ Platform
Vaccine Delivery for Infectious Diseases
Pre-clinicalActive
Key Facts
About Verndari
Verndari is a private, pre-clinical stage biotech company pioneering the VaxiPatch™, a proprietary intradermal microarray patch for vaccine delivery. The technology aims to address critical challenges in global immunization by offering a pain-free, thermostable, and dose-sparing alternative to traditional needles and syringes. With a leadership team combining biopharmaceutical operations and legal expertise, the company is focused on advancing its platform through pre-clinical studies. Its value proposition centers on simplifying administration, reducing costs, and improving vaccine access worldwide.
View full company profile